| 1 |
Myocardial Fas ligand expression increases susceptibility to AZT-induced cardiomyopathy.Cardiovasc Toxicol. 2007;7(4):255-63. doi: 10.1007/s12012-007-9004-9. Epub 2007 Oct 18.
|
| 2 |
An abnormal gene expression of the beta-adrenergic system contributes to the pathogenesis of cardiomyopathy in cirrhotic rats.Hepatology. 2008 Dec;48(6):1913-23. doi: 10.1002/hep.22533.
|
| 3 |
Interrelation between Expression of ADAM 10 and MMP 9 and Synthesis of Peroxynitrite in Doxorubicin Induced Cardiomyopathy.Biomol Ther (Seoul). 2013 Sep 30;21(5):371-80. doi: 10.4062/biomolther.2013.034.
|
| 4 |
Type 5 adenylyl cyclase increases oxidative stress by transcriptional regulation of manganese superoxide dismutase via the SIRT1/FoxO3a pathway.Circulation. 2013 Apr 23;127(16):1692-701. doi: 10.1161/CIRCULATIONAHA.112.001212. Epub 2013 Mar 27.
|
| 5 |
Cardioprotective effect of endogenous pituitary adenylate cyclase-activating polypeptide on Doxorubicin-induced cardiomyopathy in mice.Circ J. 2010 Jun;74(6):1183-90. doi: 10.1253/circj.cj-09-1024. Epub 2010 Apr 6.
|
| 6 |
Effects of cardiac-restricted overexpression of the A(2A) adenosine receptor on adriamycin-induced cardiotoxicity.Am J Physiol Heart Circ Physiol. 2010 Jun;298(6):H1738-47. doi: 10.1152/ajpheart.00688.2009. Epub 2010 Apr 2.
|
| 7 |
Disruption of type 5 adenylyl cyclase prevents -adrenergic receptor cardiomyopathy: a novel approach to -adrenergic receptor blockade.Am J Physiol Heart Circ Physiol. 2014 Nov 15;307(10):H1521-8. doi: 10.1152/ajpheart.00491.2014. Epub 2014 Sep 5.
|
| 8 |
Upregulation of vasopressin V2 and aquaporin 2 in the inner medullary collecting duct of cardiomyopathic hamsters is attenuated by enalapril treatment.Metabolism. 2002 Aug;51(8):970-5. doi: 10.1053/meta.2002.34015.
|
| 9 |
Opposing roles of Akt and STAT3 in the protection of the maternal heart from peripartum stress.Cardiovasc Res. 2014 Mar 15;101(4):587-96. doi: 10.1093/cvr/cvu010. Epub 2014 Jan 20.
|
| 10 |
The preventive effects of edible folic acid on cardiomyocyte apoptosis and survival in early onset triple-transgenic Alzheimer's disease model mice.Environ Toxicol. 2018 Jan;33(1):83-92. doi: 10.1002/tox.22498. Epub 2017 Oct 25.
|
| 11 |
Characterization of the regulatory mechanisms of activating transcription factor 3 by hypertrophic stimuli in rat cardiomyocytes.PLoS One. 2014 Aug 19;9(8):e105168. doi: 10.1371/journal.pone.0105168. eCollection 2014.
|
| 12 |
Altered baroreflex control of heart rate in bradykinin B2-receptor knockout mice.Immunopharmacology. 1999 Dec;45(1-3):21-7. doi: 10.1016/s0162-3109(99)00053-3.
|
| 13 |
Interstitial fibrosis and microvascular disease of the heart in uremia: amelioration by a calcimimetic.Lab Invest. 2009 May;89(5):520-30. doi: 10.1038/labinvest.2009.7. Epub 2009 Feb 2.
|
| 14 |
Inhibition of doxorubicin chronic toxicity in catalase-overexpressing transgenic mouse hearts.Chem Res Toxicol. 2002 Jan;15(1):1-6. doi: 10.1021/tx015532n.
|
| 15 |
Human carbonyl reductase overexpression in the heart advances the development of doxorubicin-induced cardiotoxicity in transgenic mice.Cancer Res. 2000 Sep 15;60(18):5158-64.
|
| 16 |
Time-dependent and tissue-specific accumulation of mtDNA and respiratory chain defects in chronic doxorubicin cardiomyopathy.Circulation. 2003 Nov 11;108(19):2423-9. doi: 10.1161/01.CIR.0000093196.59829.DF. Epub 2003 Oct 20.
|
| 17 |
Left ventricular non-compaction associated with a genetic variant of the CYP2C9 gene.Heart Lung Circ. 2006 Aug;15(4):269-71. doi: 10.1016/j.hlc.2006.02.007. Epub 2006 Apr 3.
|
| 18 |
Intolerance to -blockade in a mouse model of -sarcoglycan-deficient muscular dystrophy cardiomyopathy.Eur J Heart Fail. 2010 Nov;12(11):1163-70. doi: 10.1093/eurjhf/hfq129. Epub 2010 Jul 30.
|
| 19 |
Increased plasma endothelin-1 and cardiac nitric oxide during doxorubicin-induced cardiomyopathy.Pharmacol Toxicol. 2001 Sep;89(3):140-4. doi: 10.1034/j.1600-0773.2001.d01-148.x.
|
| 20 |
Erythropoietin protects against doxorubicin-induced cardiomyopathy via a phosphatidylinositol 3-kinase-dependent pathway.J Pharmacol Exp Ther. 2008 Jan;324(1):160-9. doi: 10.1124/jpet.107.125773. Epub 2007 Oct 10.
|
| 21 |
Endogenous sulfur dioxide protects against isoproterenol-induced myocardial injury and increases myocardial antioxidant capacity in rats.Lab Invest. 2011 Jan;91(1):12-23. doi: 10.1038/labinvest.2010.156. Epub 2010 Aug 23.
|
| 22 |
Cardiac-specific ablation of G-protein receptor kinase 2 redefines its roles in heart development and beta-adrenergic signaling.Circ Res. 2006 Oct 27;99(9):996-1003. doi: 10.1161/01.RES.0000247932.71270.2c. Epub 2006 Sep 28.
|
| 23 |
Treatment with an adenoviral vector encoding hepatocyte growth factor mitigates established cardiac dysfunction in doxorubicin-induced cardiomyopathy.Am J Physiol Heart Circ Physiol. 2008 Feb;294(2):H1048-57. doi: 10.1152/ajpheart.01102.2007. Epub 2007 Dec 14.
|
| 24 |
Hsp10 and Hsp60 modulate Bcl-2 family and mitochondria apoptosis signaling induced by doxorubicin in cardiac muscle cells.J Mol Cell Cardiol. 2003 Sep;35(9):1135-43. doi: 10.1016/s0022-2828(03)00229-3.
|
| 25 |
[The relationship of blood glucose and the expression of insulin-like growth factor-1 receptor mRNA in diabetic cardiomyopathy: a preliminary study with rats].Zhonghua Yi Xue Za Zhi. 2007 May 15;87(18):1249-51.
|
| 26 |
Cytokine expression in the muscle of HIV-infected patients: evidence for interleukin-1 alpha accumulation in mitochondria of AZT fibers. Ann Neurol. 1994 Nov;36(5):752-8. doi: 10.1002/ana.410360511.
|
| 27 |
Cardiotoxicity and cardioprotection during chemotherapy.Curr Opin Oncol. 1995 Jul;7(4):304-9. doi: 10.1097/00001622-199507000-00002.
|
| 28 |
Combined deficiency of dystrophin and beta1 integrin in the cardiac myocyte causes myocardial dysfunction, fibrosis and calcification.Circ Res. 2008 May 9;102(9):1109-17. doi: 10.1161/CIRCRESAHA.108.173153. Epub 2008 Mar 13.
|
| 29 |
Protection against doxorubicin cardiomyopathy in rats: role of phosphodiesterase inhibitors type 4.J Pharm Pharmacol. 2004 Jun;56(6):757-68. doi: 10.1211/0022357023565.
|
| 30 |
Lipolysis is an important determinant of isoproterenol-induced myocardial necrosis.Cardiovasc Pathol. 1999 Sep-Oct;8(5):255-61. doi: 10.1016/s1054-8807(99)00017-4.
|
| 31 |
14-3-3 protein regulates Ask1 signaling and protects against diabetic cardiomyopathy.Biochem Pharmacol. 2008 May 1;75(9):1797-806. doi: 10.1016/j.bcp.2008.02.003. Epub 2008 Feb 12.
|
| 32 |
Cocaine and apoptosis in myocardial cells.Anat Rec. 1999 Dec 15;257(6):208-16. doi: 10.1002/(SICI)1097-0185(19991215)257:6<208::AID-AR6>3.0.CO;2-0.
|
| 33 |
Endotoxin-induced myocardial dysfunction: effects of macrophage migration inhibitory factor neutralization.Circ Res. 2005 May 27;96(10):1095-102. doi: 10.1161/01.RES.0000168327.22888.4d. Epub 2005 May 5.
|
| 34 |
A common MYBPC3 (cardiac myosin binding protein C) variant associated with cardiomyopathies in South Asia.Nat Genet. 2009 Feb;41(2):187-91. doi: 10.1038/ng.309. Epub 2009 Jan 18.
|
| 35 |
Clinical diversity of MYH7-related cardiomyopathies: Insights into genotype-phenotype correlations.Am J Med Genet A. 2019 Mar;179(3):365-372. doi: 10.1002/ajmg.a.61017. Epub 2018 Dec 27.
|
| 36 |
Altered contractile response due to increased beta3-adrenoceptor stimulation in diabetic cardiomyopathy: the role of nitric oxide synthase 1-derived nitric oxide.Anesthesiology. 2007 Sep;107(3):452-60. doi: 10.1097/01.anes.0000278909.40408.24.
|
| 37 |
Plasma concentrations of NT-pro-BNP and cardiac troponin-I in relation to doxorubicin-induced cardiomyopathy and cardiac function in childhood malignancy.Saudi Med J. 2005 Aug;26(8):1197-202.
|
| 38 |
Doxorubicin-induced expression of LOX-1 in H9c2 cardiac muscle cells and its role in apoptosis.Biochem Biophys Res Commun. 2005 Sep 16;335(1):188-96. doi: 10.1016/j.bbrc.2005.07.064.
|
| 39 |
Inflammatory and age-related pathologies in mice with ectopic expression of human PARP-1.Mech Ageing Dev. 2010 Jun;131(6):389-404. doi: 10.1016/j.mad.2010.05.005. Epub 2010 Jun 8.
|
| 40 |
Comparative phenotypic assessment of cardiac pathology, physiology, and gene expression in C3H/HeJ, C57BL/6J, and B6C3F1/J mice.Toxicol Pathol. 2010 Oct;38(6):923-42. doi: 10.1177/0192623310382864.
|
| 41 |
Peroxisome proliferator-activated receptor {delta} is an essential transcriptional regulator for mitochondrial protection and biogenesis in adult heart.Circ Res. 2010 Mar 19;106(5):911-9. doi: 10.1161/CIRCRESAHA.109.206185. Epub 2010 Jan 14.
|
| 42 |
Protein kinase Cepsilon overexpression alters myofilament properties and composition during the progression of heart failure.Circ Res. 2004 Aug 20;95(4):424-32. doi: 10.1161/01.RES.0000138299.85648.92. Epub 2004 Jul 8.
|
| 43 |
Disparate impact of butyroyloxymethyl diethylphosphate (AN-7), a histone deacetylase inhibitor, and doxorubicin in mice bearing a mammary tumor.PLoS One. 2012;7(2):e31393. doi: 10.1371/journal.pone.0031393. Epub 2012 Feb 23.
|
| 44 |
Thrombopoietin protects against in vitro and in vivo cardiotoxicity induced by doxorubicin.Circulation. 2006 May 9;113(18):2211-20. doi: 10.1161/CIRCULATIONAHA.105.560250. Epub 2006 May 1.
|
| 45 |
Modulation of doxorubicin-induced cardiac dysfunction in toll-like receptor-2-knockout mice.Circulation. 2004 Nov 2;110(18):2869-74. doi: 10.1161/01.CIR.0000146889.46519.27. Epub 2004 Oct 25.
|
| 46 |
Antioxidants and tumor necrosis factor alpha-inhibiting activity of sesame oil against doxorubicin-induced cardiotoxicity.Ther Adv Cardiovasc Dis. 2014 Feb;8(1):4-11. doi: 10.1177/1753944713516532. Epub 2014 Jan 17.
|
| 47 |
Targeted panel sequencing in pediatric primary cardiomyopathy supports a critical role of TNNI3.Clin Genet. 2019 Dec;96(6):549-559. doi: 10.1111/cge.13645. Epub 2019 Oct 22.
|
| 48 |
In vitro and in vivo examination of cardiac troponins as biochemical markers of drug-induced cardiotoxicity.Toxicology. 2007 Jul 31;237(1-3):218-228. doi: 10.1016/j.tox.2007.05.016. Epub 2007 May 24.
|
| 49 |
Overexpression of thioredoxin-1 in transgenic mice attenuates adriamycin-induced cardiotoxicity.Circulation. 2002 Sep 10;106(11):1403-9. doi: 10.1161/01.cir.0000027817.55925.b4.
|
| 50 |
Elevated expression of urotensin II and its receptor in diabetic cardiomyopathy.J Diabetes Complications. 2008 Mar-Apr;22(2):137-43. doi: 10.1016/j.jdiacomp.2006.10.008.
|
| 51 |
Xanthine oxidase inhibition alleviates the cardiac complications of insulin resistance: effect on low grade inflammation and the angiotensin system.J Transl Med. 2015 Mar 6;13:82. doi: 10.1186/s12967-015-0445-9.
|
| 52 |
Mutant NDUFS3 subunit of mitochondrial complex I causes Leigh syndrome. J Med Genet. 2004 Jan;41(1):14-7. doi: 10.1136/jmg.2003.014316.
|
| 53 |
Mutations in myotilin cause myofibrillar myopathy.Neurology. 2004 Apr 27;62(8):1363-71. doi: 10.1212/01.wnl.0000123576.74801.75.
|
| 54 |
[Screening of differentially expressed genes in rats with cardiomyopathy after bone marrow mesenchymal stem cell transplantation].Zhonghua Er Ke Za Zhi. 2006 Oct;44(10):787-91.
|
| 55 |
Involvement of human monogenic cardiomyopathy genes in experimental polygenic cardiac hypertrophy.Physiol Genomics. 2018 Sep 1;50(9):680-687. doi: 10.1152/physiolgenomics.00143.2017. Epub 2018 May 18.
|
| 56 |
Recessive mutations in EPG5 cause Vici syndrome, a multisystem disorder with defective autophagy. Nat Genet. 2013 Jan;45(1):83-7. doi: 10.1038/ng.2497. Epub 2012 Dec 9.
|
| 57 |
Total triterpene acids, active ingredients from Fructus Corni, attenuate diabetic cardiomyopathy by normalizing ET pathway and expression of FKBP12.6 and SERCA2a in streptozotocin-rats.J Pharm Pharmacol. 2008 Dec;60(12):1687-94. doi: 10.1211/jpp/60.12.0016.
|
| 58 |
Transgenic expression of {alpha}7{beta}1 integrin maintains muscle integrity, increases regenerative capacity, promotes hypertrophy, and reduces cardiomyopathy in dystrophic mice.Am J Pathol. 2005 Jan;166(1):253-63. doi: 10.1016/s0002-9440(10)62249-3.
|
| 59 |
Constitutively active phosphatase inhibitor-1 improves cardiac contractility in young mice but is deleterious after catecholaminergic stress and with aging.J Clin Invest. 2010 Feb;120(2):617-26. doi: 10.1172/JCI40545. Epub 2010 Jan 11.
|
| 60 |
Retrospective, multicentric study of 180 children with cytochrome C oxidase deficiency.Pediatr Res. 2006 Jan;59(1):21-6. doi: 10.1203/01.pdr.0000190572.68191.13. Epub 2005 Dec 2.
|
| 61 |
Hydrogen gas attenuates embryonic gene expression and prevents left ventricular remodeling induced by intermittent hypoxia in cardiomyopathic hamsters.Am J Physiol Heart Circ Physiol. 2014 Dec 1;307(11):H1626-33. doi: 10.1152/ajpheart.00228.2014. Epub 2014 Oct 3.
|
| 62 |
Role of PRL-3, a human muscle-specific tyrosine phosphatase, in angiotensin-II signaling.Biochem Biophys Res Commun. 2001 May 25;283(5):1061-8. doi: 10.1006/bbrc.2001.4881.
|
| 63 |
The roles of MMP-2/TIMP-2 in extracellular matrix remodelling in the hearts of STZ-induced diabetic rats.Acta Cardiol. 2007 Oct;62(5):485-91. doi: 10.2143/AC.62.5.2023412.
|
| 64 |
TMEM70 mutations cause isolated ATP synthase deficiency and neonatal mitochondrial encephalocardiomyopathy. Nat Genet. 2008 Nov;40(11):1288-90. doi: 10.1038/ng.246. Epub 2008 Oct 26.
|
| 65 |
Muscle ring finger 1 mediates cardiac atrophy in vivo.Am J Physiol Heart Circ Physiol. 2009 Apr;296(4):H997-H1006. doi: 10.1152/ajpheart.00660.2008. Epub 2009 Jan 23.
|
|
|
|
|
|
|
